CELLEBRITE DI LTD (CLBT) Fundamental Analysis & Valuation

NASDAQ:CLBT • IL0011794802

Current stock price

14.1 USD
+0.1 (+0.71%)
At close:
14 USD
-0.1 (-0.71%)
Pre-Market:

This CLBT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. CLBT Profitability Analysis

1.1 Basic Checks

  • In the past year CLBT was profitable.
  • In the past year CLBT had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: CLBT reported negative net income in multiple years.
  • In the past 5 years CLBT always reported a positive cash flow from operatings.
CLBT Yearly Net Income VS EBIT VS OCF VS FCFCLBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 8.29%, CLBT belongs to the top of the industry, outperforming 83.27% of the companies in the same industry.
  • CLBT has a Return On Equity of 16.07%. This is amongst the best in the industry. CLBT outperforms 83.27% of its industry peers.
  • The Return On Invested Capital of CLBT (10.09%) is better than 84.73% of its industry peers.
  • CLBT had an Average Return On Invested Capital over the past 3 years of 10.94%. This is in line with the industry average of 10.99%.
Industry RankSector Rank
ROA 8.29%
ROE 16.07%
ROIC 10.09%
ROA(3y)-15.97%
ROA(5y)0.32%
ROE(3y)-101.74%
ROE(5y)N/A
ROIC(3y)10.94%
ROIC(5y)9.54%
CLBT Yearly ROA, ROE, ROICCLBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200

1.3 Margins

  • With an excellent Profit Margin value of 16.36%, CLBT belongs to the best of the industry, outperforming 82.91% of the companies in the same industry.
  • CLBT's Profit Margin has declined in the last couple of years.
  • The Operating Margin of CLBT (13.98%) is better than 80.73% of its industry peers.
  • CLBT's Operating Margin has improved in the last couple of years.
  • With an excellent Gross Margin value of 84.20%, CLBT belongs to the best of the industry, outperforming 90.18% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CLBT has remained more or less at the same level.
Industry RankSector Rank
OM 13.98%
PM (TTM) 16.36%
GM 84.2%
OM growth 3Y235.7%
OM growth 5Y24.25%
PM growth 3Y-27.48%
PM growth 5YN/A
GM growth 3Y1.2%
GM growth 5Y0.89%
CLBT Yearly Profit, Operating, Gross MarginsCLBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. CLBT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CLBT is creating some value.
  • Compared to 1 year ago, CLBT has more shares outstanding
  • The number of shares outstanding for CLBT has been increased compared to 5 years ago.
  • There is no outstanding debt for CLBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CLBT Yearly Shares OutstandingCLBT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CLBT Yearly Total Debt VS Total AssetsCLBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • CLBT has an Altman-Z score of 5.52. This indicates that CLBT is financially healthy and has little risk of bankruptcy at the moment.
  • CLBT's Altman-Z score of 5.52 is fine compared to the rest of the industry. CLBT outperforms 78.18% of its industry peers.
  • There is no outstanding debt for CLBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 5.52
ROIC/WACC1.15
WACC8.81%
CLBT Yearly LT Debt VS Equity VS FCFCLBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • CLBT has a Current Ratio of 1.56. This is a normal value and indicates that CLBT is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.56, CLBT is in line with its industry, outperforming 46.55% of the companies in the same industry.
  • CLBT has a Quick Ratio of 1.54. This is a normal value and indicates that CLBT is financially healthy and should not expect problems in meeting its short term obligations.
  • CLBT has a Quick ratio (1.54) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.54
CLBT Yearly Current Assets VS Current LiabilitesCLBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. CLBT Growth Analysis

3.1 Past

  • CLBT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.05%, which is quite good.
  • The Earnings Per Share has been growing by 71.00% on average over the past years. This is a very strong growth
  • Looking at the last year, CLBT shows a quite strong growth in Revenue. The Revenue has grown by 18.56% in the last year.
  • Measured over the past years, CLBT shows a quite strong growth in Revenue. The Revenue has been growing by 19.54% on average per year.
EPS 1Y (TTM)19.05%
EPS 3Y71%
EPS 5YN/A
EPS Q2Q%40%
Revenue 1Y (TTM)18.56%
Revenue growth 3Y20.67%
Revenue growth 5Y19.54%
Sales Q2Q%18.13%

3.2 Future

  • Based on estimates for the next years, CLBT will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.40% on average per year.
  • Based on estimates for the next years, CLBT will show a quite strong growth in Revenue. The Revenue will grow by 16.23% on average per year.
EPS Next Y11.32%
EPS Next 2Y12.57%
EPS Next 3Y16.24%
EPS Next 5Y16.4%
Revenue Next Year19.73%
Revenue Next 2Y18.6%
Revenue Next 3Y17.73%
Revenue Next 5Y16.23%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CLBT Yearly Revenue VS EstimatesCLBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M
CLBT Yearly EPS VS EstimatesCLBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

4

4. CLBT Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 28.20, CLBT can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Earnings ratio as CLBT.
  • CLBT's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.21.
  • A Price/Forward Earnings ratio of 25.33 indicates a quite expensive valuation of CLBT.
  • The rest of the industry has a similar Price/Forward Earnings ratio as CLBT.
  • When comparing the Price/Forward Earnings ratio of CLBT to the average of the S&P500 Index (23.13), we can say CLBT is valued inline with the index average.
Industry RankSector Rank
PE 28.2
Fwd PE 25.33
CLBT Price Earnings VS Forward Price EarningsCLBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CLBT is valued a bit cheaper than 63.27% of the companies in the same industry.
  • 69.45% of the companies in the same industry are more expensive than CLBT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 21.94
EV/EBITDA 35.32
CLBT Per share dataCLBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of CLBT may justify a higher PE ratio.
  • CLBT's earnings are expected to grow with 16.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.49
PEG (5Y)N/A
EPS Next 2Y12.57%
EPS Next 3Y16.24%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CLBT Dividend Analysis

5.1 Amount

  • No dividends for CLBT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CLBT Fundamentals: All Metrics, Ratios and Statistics

CELLEBRITE DI LTD

NASDAQ:CLBT (4/6/2026, 8:28:27 PM)

Premarket: 14 -0.1 (-0.71%)

14.1

+0.1 (+0.71%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-11
Earnings (Next)05-12
Inst Owners49.03%
Inst Owner Change0%
Ins Owners0.63%
Ins Owner Change0%
Market Cap3.52B
Revenue(TTM)475.68M
Net Income(TTM)77.81M
Analysts83.08
Price Target22.44 (59.15%)
Short Float %3.88%
Short Ratio2.4
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.42%
Min EPS beat(2)1.3%
Max EPS beat(2)9.55%
EPS beat(4)4
Avg EPS beat(4)9.89%
Min EPS beat(4)1.3%
Max EPS beat(4)15.93%
EPS beat(8)8
Avg EPS beat(8)28.1%
EPS beat(12)12
Avg EPS beat(12)50.82%
EPS beat(16)13
Avg EPS beat(16)30.81%
Revenue beat(2)1
Avg Revenue beat(2)0.53%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)1.27%
Revenue beat(4)1
Avg Revenue beat(4)-0.89%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)1.27%
Revenue beat(8)4
Avg Revenue beat(8)0.17%
Revenue beat(12)8
Avg Revenue beat(12)1.06%
Revenue beat(16)8
Avg Revenue beat(16)-0.34%
PT rev (1m)0%
PT rev (3m)-10.98%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.14%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.15%
Valuation
Industry RankSector Rank
PE 28.2
Fwd PE 25.33
P/S 7.39
P/FCF 21.94
P/OCF 20.27
P/B 7.26
P/tB 12.42
EV/EBITDA 35.32
EPS(TTM)0.5
EY3.55%
EPS(NY)0.56
Fwd EY3.95%
FCF(TTM)0.64
FCFY4.56%
OCF(TTM)0.7
OCFY4.93%
SpS1.91
BVpS1.94
TBVpS1.14
PEG (NY)2.49
PEG (5Y)N/A
Graham Number4.67
Profitability
Industry RankSector Rank
ROA 8.29%
ROE 16.07%
ROCE 11.68%
ROIC 10.09%
ROICexc 43.46%
ROICexgc N/A
OM 13.98%
PM (TTM) 16.36%
GM 84.2%
FCFM 33.7%
ROA(3y)-15.97%
ROA(5y)0.32%
ROE(3y)-101.74%
ROE(5y)N/A
ROIC(3y)10.94%
ROIC(5y)9.54%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)12.66%
ROCE(5y)11.04%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y205.37%
ROICexc growth 5YN/A
OM growth 3Y235.7%
OM growth 5Y24.25%
PM growth 3Y-27.48%
PM growth 5YN/A
GM growth 3Y1.2%
GM growth 5Y0.89%
F-Score5
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 111.44%
Cap/Sales 2.78%
Interest Coverage 250
Cash Conversion 221.51%
Profit Quality 206.03%
Current Ratio 1.56
Quick Ratio 1.54
Altman-Z 5.52
F-Score5
WACC8.81%
ROIC/WACC1.15
Cap/Depr(3y)96.85%
Cap/Depr(5y)101.03%
Cap/Sales(3y)2.62%
Cap/Sales(5y)2.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.05%
EPS 3Y71%
EPS 5YN/A
EPS Q2Q%40%
EPS Next Y11.32%
EPS Next 2Y12.57%
EPS Next 3Y16.24%
EPS Next 5Y16.4%
Revenue 1Y (TTM)18.56%
Revenue growth 3Y20.67%
Revenue growth 5Y19.54%
Sales Q2Q%18.13%
Revenue Next Year19.73%
Revenue Next 2Y18.6%
Revenue Next 3Y17.73%
Revenue Next 5Y16.23%
EBIT growth 1Y16.82%
EBIT growth 3Y305.1%
EBIT growth 5Y48.52%
EBIT Next Year28.35%
EBIT Next 3Y23.3%
EBIT Next 5Y22.88%
FCF growth 1Y31.88%
FCF growth 3Y140.74%
FCF growth 5Y21.59%
OCF growth 1Y31.3%
OCF growth 3Y103.54%
OCF growth 5Y21.14%

CELLEBRITE DI LTD / CLBT Fundamental Analysis FAQ

What is the fundamental rating for CLBT stock?

ChartMill assigns a fundamental rating of 6 / 10 to CLBT.


What is the valuation status of CELLEBRITE DI LTD (CLBT) stock?

ChartMill assigns a valuation rating of 4 / 10 to CELLEBRITE DI LTD (CLBT). This can be considered as Fairly Valued.


How profitable is CELLEBRITE DI LTD (CLBT) stock?

CELLEBRITE DI LTD (CLBT) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for CLBT stock?

The Price/Earnings (PE) ratio for CELLEBRITE DI LTD (CLBT) is 28.2 and the Price/Book (PB) ratio is 7.26.


Can you provide the dividend sustainability for CLBT stock?

The dividend rating of CELLEBRITE DI LTD (CLBT) is 0 / 10 and the dividend payout ratio is 0%.